Codon 72 Polymorphism and Various Human Papillomavirus 16 E 6 Genotypes Are Risk Factors for Cervical Cancer Development 1
暂无分享,去创建一个
G. Voglino | E. Wilander | M. Tommasino | L. Edler | H. Delius | I. Zehbe | A. Marongiu | F. Klimek | S. Andersson
[1] Ranajit Chakraborty,et al. p53 codon 72 polymorphism and risk of cervical cancer. , 2003, Biological research.
[2] E. Franco,et al. p53 polymorphism in codon 72 and risk of human papillomavirus‐induced cervical cancer: effect of inter‐laboratory variation , 2000, International journal of cancer.
[3] T. Agorastos,et al. p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women. , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[4] C. Meijer,et al. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. , 2000, The Journal of general virology.
[5] G. Voglino,et al. Codon 72 polymorphism of p53 and its association with cervical cancer , 1999, The Lancet.
[6] M. von Knebel Doeberitz,et al. No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer , 1999, Journal of Molecular Medicine.
[7] Patrik K. E. Magnusson,et al. p53 polymorphism and risk of cervical cancer , 1998, Nature.
[8] H. Hollema,et al. Homozygous arginine-72 in wild type p53 and risk of cervical cancer , 1998, The Lancet.
[9] R. Gornall,et al. p53 polymorphism and risk of cervical cancer , 1998, The Lancet.
[10] G. Voglino,et al. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms , 1998, The Lancet.
[11] Y. Nakamura,et al. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. , 1998, Cancer research.
[12] I. Jacobs,et al. p53 codon 72 polymorphism and risk of cervical cancer in UK , 1998, The Lancet.
[13] Irene M. Leigh,et al. Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer , 1998, Nature.
[14] E. Wilander,et al. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. , 1998, Cancer research.
[15] C. Wheeler,et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective , 1997, Journal of virology.
[16] J. Cuzick,et al. Human papillomavirus genotype as a predictor of persistence and development of high‐grade lesions in women with minor cervical abnormalities , 1996, International journal of cancer.
[17] R. Birgander,et al. Is p53 polymorphism maintained by natural selection? , 1994, Human heredity.
[18] H. Hausen. Human papillomaviruses in the pathogenesis of anogenital cancer. , 1991 .
[19] S. Suhai,et al. Human papillomavirus type 16 DNA sequence. , 1985, Virology.
[20] D. Mayer,et al. Biochemical microanalysis of glycogen content and glucose-6-phosphate dehydrogenase activity in focal lesions of the rat liver induced by N-nitrosomorpholine. , 1984, Carcinogenesis.